Variable | OR (95% CI) | P value |
---|---|---|
Sex (male vs. female) | 0.72 (0.31–1.67) | 0.445 |
Age (≤ 65 vs. > 65) | 1.51 (0.79–2.91) | 0.214 |
Diversion type (conduit vs. cutaneous ureterostomy) | 2.09 (1.01–4.31) | 0.047 |
Diversion type (neobladder vs. cutaneous ureterostomy) | 2.47 (1.01–6.05) | 0.048 |
Pathological T-stage (MIBC vs. NMIBC) | 1.10 (0.58–2.07) | 0.780 |
Pathological N-stage (N + vs. N−) | 1.68 (0.58–4.85) | 0.339 |
Smoking history (yes vs. no) | 1.36 (0.72–2.59) | 0.345 |
Neoadjuvant chemotherapy (yes vs. no) | 1.48 (0.60–3.67) | 0.397 |
Surgical experience (continuous) | 1.05 (1.03–1.07) | < 0.001 |